Events Search and Views Navigation
October 2019
Institut Pasteur – International Course on Antibiotics and Resistance (ICARE)
Speakers include Erin Duffy, CARB-X Chief of Research and Development. The emergence and spread of bacteria resistant to many drug classes seriously threaten all branches of modern medicine. There is currently no course providing advanced instruction on antibiotics and resistance. The specific goal of ICARe is to bring leaders in academics and industry together with trained scientists at the dawn of their careers. Cutting-edge approaches for detection of resistance and antibiotic discovery, chemical optimization, and usage that minimizes the development…
Find out more »November 2019
World Anti-Microbial Resistance Congress 2019
Kevin Outterson, Executive Director of CARB-X, will be giving the keynote Address on November 7th, titled "A vision for a health antibiotic R&D ecosystem". Outterson will also be participating on a panel titled "Analyzing the potential impact of current commercial and “pull” initiatives" on November 7th. Karen Gallant, Deputy Executive Director of CARB-X, will be presenting on November 7th on "Accelerating innovation to fight drug-resistant bacteria". About the World AMR Congress: Since 2015, the World Anti-Microbial Resistance Congress has been…
Find out more »Live Webinar: GARDP/REVIVE – Converting Gram-positive-only compounds into broad-spectrum antibiotics
This webinar by Paul Hergenrother (Department of Chemistry and the Institute for Genomic Biology University of Illinois, US) will detail his research group's efforts to understand compound accumulation in the Gram-negative ESKAPE pathogens. Emphasis will be placed on the practicality, actionability, and translatability of this information, specifically, the use of accumulation rules to convert high-value Gram-positive-only compounds into antibiotics with activity against key Gram-negative pathogens. The presentation will be followed by a Q&A session. Speaker: Paul Hergenrother, Kenneth L. Rinehart…
Find out more »CRISPR and Gene Editing: The New Frontier in Fighting Infectious Diseases?
Presenters include Karen Gallant, Deputy Executive Director of CARB-X. Few technologies have the potential to disrupt and eliminate infectious disease and viral infections– but gene editing, CRISPR in particular, is a latent technology that could change biotech – and we’re just seeing the beginning of what effect it could have on the world. With scientific promise comes interest from investors – a surge of biotech startups are utilizing CRISPR technology for many different applications such as at-home testing, in-clinic uses,…
Find out more »The 2019 Canada Gairdner Foundation / Ontario International Symposium: Fuelling the Fight against AMR – Global Innovations in Research & Discovery
Kevin Outterson, Executive Director of CARB-X, who be participating in a special panel discussion titled "When antibiotics fail: An international conversation about the worrisome evidence of impact and what can be done". During this session, a panel of international experts will discuss the findings from a new report by the Council of Canadian Academies and discuss what steps can be taken to reduce the impact of rising resistance rates around the world. Additional panelists include Prof. Andrew Morris, Prof. Dame…
Find out more »FDA Workshop: Enhancing the Clinical Trial Enterprise for Antibacterial Drug Development in the United States
Presenters include Kevin Outterson, Executive Director of CARB-X, and Erin Duffy, CARB-X Chief of Research and Development. The FDA, IDSA, NIAID and Pew are co-sponsoring this workshop to focus on Enhancing the Clinical Trial Enterprise for Antibacterial Drug Development in the United States. This workshop will bring together a diverse array of subject matter experts in the fields of infectious diseases (ID), academics and industry and other government bodies to better understand the current state of U.S. based ID trials…
Find out more »